Zimmer Holdings has officially completed the $14 billion acquisition of Biomet following the receipt of U.S. Federal Trade Commission clearance.
The company, now known as Zimmer Biomet Holdings, will trade under the symbol ZBH on the New York Stock Exchange and SIX Swiss Exchange beginning June 29, 2015.
"The coming together of Zimmer and Biomet is a momentous achievement," David Dvorak, president and CEO of Zimmer Biomet, said in a release. "Over the past several months, our integration planning teams have been working to ensure that we capture the best of both companies and create a seamless and efficient transition."
The European Commission and the Japan Fair Trade Commission previously cleared the acquisition, which was first announced in April 2014. Zimmer Biomet will continue to offer dental implants and other products.